What archeogenetics tells us about liver steatosis in ancient and modern humans

Ancient genomes show that the main genetic variant responsible for fatty liver diseases dates back to beyond the split from Neanderthals, where it reached 100% frequency, perhaps due to advantages in cold adaptation.

Researchers have discovered that the primary gene variant responsible for fatty liver diseases originated before humans split from Neanderthals. This particular variety may have been advantageous in adapting to cold climates, thus reaching 100% prevalence.

Originamitteilung:

Ancient genomes show that the main genetic variant responsible for fatty liver diseases dates back to beyond the split from Neanderthals, where it reached 100% frequency, perhaps due to advantages in cold adaptation.

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

Neues Kliniknetzwerk zu Long Covid bei Kindern und Jugendlichen

Das Bundesgesundheitsministerium fördert künftig vier Projekte zu langfristigen Folgen von Covid-19 bei Kindern und Jugendlichen mit insgesamt knapp 45 Millionen Euro. Darunter ist auch das mit 41 Millionen Euro geförderte Konsortium PEDNET-LC, das am Klinikum der Technischen Universität München (TUM Universitätsklinikum) koordiniert wird. Im Rahmen des Projekts werden bundesweit 20 spezialisierte Versorgungszentren für Kinder und Jugendliche mit Long Covid und verwandten Erkrankungen aufgebaut und neue Forschungsinfrastrukturen zu diesem Thema geschaffen.

Read More

Increased Risk of Dementia? Study Evaluates Digital Memory Tests for Home Use

With the involvement of around 30 specialist practices across Germany, DZNE will investigate whether dedicated memory tests on smartphones can help to detect mild cognitive impairment (MCI) at an early stage. Such symptoms can indicate an increased risk of dementia. To this end, an app developed by the Magdeburg start-up “neotiv” will be used as a digital tool. The test results recorded by the app are intended to assist doctor’s in their diagnosis. “Lilly Deutschland GmbH” is another project partner: the pharmaceutical company is funding the health care study with 1.3 million euros.

Read More